Company Filing History:
2 out of 7 
1 out of 2 
1 out of 4 Years Active: 2008-2012
Title: Michael Taeger: Innovator in Medical Science
Introduction
Michael Taeger is a notable inventor based in Heinrichsberg, Germany. He has made significant contributions to the field of medical science, particularly through his innovative patents. With a total of 2 patents, Taeger has focused on developing solutions for various health-related issues.
Latest Patents
One of Taeger's latest patents is titled "Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological inflammatory, neuronal and other diseases." This invention relates to substances that can specifically inhibit certain peptidases, which are crucial for medical applications. The patent emphasizes the use of these substances in treating diseases characterized by excessive immune responses, chronic inflammatory conditions, neuronal diseases, skin disorders, and specific viral infections, including SARS.
Another significant patent is "Medicament containing an effector of the glutathione metabolism together with α-lipoic acid for treating diabetes mellitus." This invention addresses the treatment of disturbances in the thiol-disulfide status, particularly in diabetes mellitus, by utilizing a medicament that combines an effector of glutathione metabolism with α-lipoic acid.
Career Highlights
Throughout his career, Michael Taeger has worked with various companies, including Imtm GmbH and Keyneurotek Pharmaceuticals AG. His work in these organizations has allowed him to further his research and development in the medical field.
Collaborations
Taeger has collaborated with notable individuals in his field, including Siegfried Ansorge and Ute Bank. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Michael Taeger is a distinguished inventor whose work has the potential to impact the medical field significantly. His innovative patents address critical health issues and demonstrate his commitment to advancing medical science.